Screening the pathogenic genes and pathways related to DMBA (7,12-dimethylbenz[a]anthracene)-induced transformation of hamster oral mucosa from precancerous lesions to squamous cell carcinoma

Oncology Letters

Volumn 2, Issue 4, 2011, Pages 637-642

  Chen, Dan ^a   Yang, Kai ^a   Mei, Jie ^a   Zhang, Guodong ^a   Lv, Xiaoqiang ^a   Xiang, Li ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Carcinoma; Gene; Oral; Pathway; Precancerous lesion; Squamous cell

Indexed keywords

BETA ACTIN; CASPASE 3; COMPLEMENTARY RNA; DIMETHYLBENZ[A]ANTHRACENE; OSTEONECTIN; RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; GENE EXPRESSION; GENOME; MALIGNANT TRANSFORMATION; MICROARRAY ANALYSIS; MOUTH CANCER; MOUTH MUCOSA; NONHUMAN; NUCLEOTIDE SEQUENCE; PRECANCER; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCREENING; SQUAMOUS CELL CARCINOMA; SYRIAN HAMSTER;

EID: 79958031317     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2011.293     Document Type: Article

References (27)

1. Kademani D, Bell RB, Schmidt BL, Blanchaert R, Fernandes R, Lambert P and Tucker WM: Oral and maxillofacial surgeons treating oral cancer: a preliminary report from the American Association of Oral and Maxillofacial Surgeons Task Force on Oral Cancer. J Oral Maxillofac Surg 66: 2151-2157, 2008.
2. Lumerman H, Freedman P and Kerpel S: Oral epithelial dysplasia and the development of invasive squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 79: 321-329, 1995.
3. Yang K, Zhang G, Mei J, Chen D and Wu M: Screening and analysis of pathogenic genes during DMBA-induced buccal mucosa carcinogenesis in golden hamsters. Oncol Rep 23: 1619&2011;1624, 2010.
4. Choi S and Myers JN: Molecular pathogenesis of oral squamous cell carcinoma: implications for therapy. J Dent Res 87: 14-32, 2008.
5. Carinci F, Lo Muzio L, Piattelli A, et al: Genetic portrait of mild and severe lingual dysplasia. Oral Oncol 41: 365-374, 2005.
6. Feng L and Wang Z: Chemopreventive effect of celecoxib in oral precancers and cancers. Laryngoscope 116: 1842-1845, 2006.
7. Gimenez-Conti IB and Slaga TJ: The hamster cheek pouch carcinogenesis model. J Cell Biochem Suppl 9: 83-90, 1993.
8. Meggiato T, Calabrese F, De Cesare CM, Baliello E, Valente M and Del Favero G: C-JUN and CPP32 (CASPASE 3) in human pancreatic cancer: relation to cell proliferation and death. Pancreas 26: 65-70, 2003.
9. Sasaki K, Natsugoe S, Ishigami S, et al: Expression of CXCL12 and its receptor CXCR4 in esophageal squamous cell carcinoma. Oncol Rep 21: 65-71, 2009.
10. Vaday GG, Peehl DM, Kadam PA and Lawrence DM: Expression of CCL5 (RANTES) and CCR5 in prostate cancer. Prostate 66: 124-134, 2006.
11. Cheadle EJ, Riyad K, Subar D, et al: Eotaxin-2 and colorectal cancer: a potential target for immune therapy. Clin Cancer Res 13: 5719-5728, 2007.
12. Joerger M, Omlin A, Cerny T and Früh M: The role of pemetrexed in advanced non small-cell lung cancer: special focus on pharmacology and mechanism of action. Curr Drug Targets 11: 37-47, 2010.
13. Jensen SA, Vainer B, Witton CJ, Jørgensen JT and Sørensen JB: Prognostic significance of numeric aberrations of genes for thymidylate synthase, thymidine phosphorylase and dihydrofolate reductase in colorectal cancer. Acta Oncol 47: 1054-1061, 2008.
14. Shimokawa H, Uramoto H, Onitsuka T, Iwata T, Nakagawa M, Ono K and Hanagiri T: TS expression predicts postoperative recurrence in adenocarcinoma of the lung. Lung Cancer: Oct 21, 2010 (Epub ahead of print).
15. Nakao S, Kuwano T, Ishibashi T, Kuwano M and Ono M: Synergistic effect of TNF-alpha in soluble VCAM-1-induced angiogenesis through alpha 4 integrins. J Immunol l70: 5704&2011;5711, 2003.
16. Gubała E, Wiench M, Oczko-Wojciechowska M, et al: Gene expression analysis by DNA microarray in papillary thyroid cancer. Endokrynol Pol 56: 752-757, 2005.
17. Heyman L, Kellouche S, Fernandes J, Dutoit S, Poulain L and Carreiras F: Vitronectin and its receptors partly mediate adhesion of ovarian cancer cells to peritoneal mesothelium in vitro. Tumour Biol 29: 231-244, 2008.
18. Heyman L, Leroy-Dudal J, Fernandes J, Seyer D, Dutoit S and Carreiras F: Mesothelial vitronectin stimulates migration of ovarian cancer cells. Cell Biol Int 34: 493-502, 2010.
19. Huvila J, Brandt A, Rojas CR, et al: Gene expression profiling of endometrial adenocarcinomas reveals increased apolipoprotein E expression in poorly differentiated tumors. Int J Gynecol Cancer 19: 1226-1231, 2009.
20. Su WP, Chen YT, Lai WW, Lin CC, Yan JJ and Su WC: Apolipo-protein E expression promotes lung adenocarcinoma proliferation and migration and as a potential survival marker in lung cancer. Lung Cancer: Apr 27, 2010 (Epub ahead of print).
21. Chen SS, Chen KK, Lin AT, Chang YH, Wu HH and Chang LS: Correlation between pre-treatment serum biochemical markers and treatment outcome for prostatic cancer with bony metastasis. J Chin Med Assoc 72: 301-306, 2009.
22. Santin AD, Zhan F, Bignotti E, et al: Gene expression profiles of primary HPV16- and HPV18-infected early stage cervical cancers and normal cervical epithelium: identification of novel candidate molecular markers for cervical cancer diagnosis and therapy. Virology 331: 269-291, 2005.
23. Fernandez-Ranvier GG, Weng J, Yeh RF, et al: Candidate diagnostic markers and tumor suppressor genes for adrenocortical carcinoma by expression profile of genes on chromosome 11q13. World J Surg 32: 873-881, 2008.
24. Podhajcer OL, Benedetti LG, Girotti MR, Prada F, Salvatierra E and Llera AS: The role of the matricellular protein SPARC in the dynamic interaction between the tumor and the host. Cancer Metastasis Rev 27: 691-705, 2008.
25. Alonso SR, Tracey L, Ortiz P, et al: A high-throughput study in melanoma identifies epithelial-mesenchymal transition as a major determinant of metastasis. Cancer Res 67: 3450-3460, 2007.
26. Briggs J, Chamboredon S, Castellazzi M, Kerry JA and Bos TJ: Transcriptional up-regulation of SPARC, in response to c-Jun overexpression, contributes to increased motility and invasion of MCF7 breast cancer cells. Oncogene 21: 7077-7091, 2002.
27. Brookman-Amissah N, Mackay AG and Swann PF: Isolation and sequencing of the cDNA of a novel cytochrome P450 from rat oesophagus. Carcinogenesis 22: 155-160, 2001.